Related by context. All words. (Click for frequent words.) 74 undetectable virus HCV 64 log# IU mL 63 8mg/kg 62 progression TTP 62 log# copies mL 60 mcg mL 60 biochemical relapse 60 PEG IFN 60 4mg/kg 60 μmol L 60 mg/m2/day 59 ug ml 59 ug kg 59 undetectable HCV RNA 59 IU ml 59 cyclophosphamide methotrexate 59 cEVR 59 mg TID 58 #mg/kg [002] 58 mg/m2 IV 58 achieved ACR# 58 aspartate aminotransferase 58 QTcF 58 % CI #.#-#.# [003] 58 TMC# [002] 58 plasma HCV RNA 58 detectable HCV RNA 58 log# reduction 58 mcg BID 58 q#h 58 #mg BID [003] 57 alanine aminotransferase ALT 57 log# 57 #mg/m# [002] 57 administered subcutaneously 57 #mg q8h 57 nM 57 IFN α 57 HBV DNA levels 57 dose cohort 57 severe neutropenia 57 mitoxantrone plus 57 elevated transaminases 57 μg mL 57 placebo p = 57 RNA copies mL 57 ribavirin RBV 57 ritonavir boosted 57 CCyR 57 virologic breakthrough 57 intravenous bolus 56 antiretroviral naïve 56 pg ml 56 pT3 56 serum HBV DNA 56 corticosteroid dose 56 mg p = 56 CRp 56 alanine aminotransferase 56 Pegasys plus Copegus 56 mL/min/#.# m 2 56 mg m² 56 HBeAg seroconversion 56 SGPT 56 atazanavir ritonavir 56 Viral load 56 Pharmacokinetics PK 56 -#.# log# 56 Median PFS 56 PSA nadir 56 plasma uric acid 56 lymphocytosis 56 SVR# 56 estramustine 56 HCV Genotype 56 undetectable HBV DNA 56 adjuvant cisplatin 56 undetectable viral 55 underwent surgical resection 55 mg kg dose 55 antithymocyte globulin 55 IU mL 55 mg QD 55 cells μL 55 lymphocyte counts 55 3mg/kg 55 Q2W 55 VELCADE melphalan 55 Cmax 55 -#.# log# copies mL 55 CR nPR 55 tipranavir r 55 μg dose 55 anagrelide 55 lymphocyte count 55 Ishak fibrosis score 55 achieved CCyR 55 response CCyR 55 PegIFN RBV 55 antibody titer 55 serum phosphate 55 creatinine ratio 55 blastic phase 55 ug dose 55 serum prostate 55 mg/m2 dose 55 abacavir lamivudine 55 #mg/m# [001] 55 mIU ml 55 #.#/#.# mmHg [001] 55 CIMZIA TM 55 pmol liter 55 azilsartan medoxomil 55 bFGF 55 hours postdose 54 HIV RNA 54 relapsed MM 54 -#.# mg dL [002] 54 oral antidiabetic medication 54 SCr 54 #ug [001] 54 rFSH 54 plus MTX 54 mg ustekinumab 54 saline placebo 54 mg orally 54 Rapid Virological Response 54 #mg QD [002] 54 ug mL 54 mg qd 54 Median progression 54 % Confidence Interval 54 dosing cohort 54 euthyroid 54 serum HCV RNA 54 pmol L 54 subcutaneous dose 54 μg ml 54 certolizumab 54 stage IIIb IV 54 serum ALT 54 ng dL 54 aspartate aminotransferase AST 54 lopinavir r 54 rapid virological response 54 mg simvastatin 54 ErbB2 positive 54 lispro 54 Decitabine 54 mcg kg 54 virologic failure 54 dalteparin 54 μg kg 54 pyrazinamide 54 plus methotrexate 54 mL/min/#.# m2 54 pg mL 54 lymphoid blast 54 huN# DM1 54 median PFS 54 ALT normalization 54 flutamide 54 Retreatment 54 lumbar spine BMD 54 AZT zidovudine Retrovir 54 non splenectomized 54 dosing cohorts 54 #mg/day [002] 54 clodronate 54 PegIFN 54 rapid virologic response 54 FOLFIRI alone 53 HCV RNA 53 CR CRu 53 serum aminotransferase levels 53 lactate dehydrogenase LDH 53 REYATAZ r arm 53 Aptivus ® 53 intramuscular dose 53 inhibitory concentration 53 cGy 53 fasting plasma glucose FPG 53 dapagliflozin plus 53 ALT elevation 53 subcutaneous enoxaparin 53 hemoglobin concentration 53 neurologic progression 53 5 Fluorouracil 53 complete cytogenetic response 53 pegylated interferon alpha 53 #mg QD [001] 53 virological response 53 liver histology 53 HBeAg positive patients 53 specific antigen PSA 53 genotypic resistance 53 piperacillin tazobactam 53 vincristine doxorubicin 53 HBsAg 53 q#d 53 μg L 53 serum calcium levels 53 HBV DNA 53 receiving prophylactic anticoagulation 53 mU liter 53 baseline neutrophil counts 53 timepoints 53 ascending doses 53 aminotransferase elevations greater 53 #.#mg/dL 53 hypophosphatemia 53 mmol l 53 Elitek 53 Flu Cy 53 TPV r 53 CC genotype 53 Lupuzor ™ 53 daily subcutaneous injections 53 HAQ DI 53 plus prednisone 53 seronegative 53 copies mL 53 antiandrogen 53 HBeAg 53 seroconverted 53 plus prednisone prednisolone 53 aged ≥ 53 gemcitabine carboplatin 53 MADRS score 53 lopinavir r arm 53 hematological parameters 53 mg RDEA# 53 ® lenalidomide 52 Peg IFN 52 CTAP# Capsules 52 nmol liter 52 ritonavir boosted atazanavir 52 peak plasma concentrations 52 ® emtricitabine 52 #mg ATC 52 ibandronate 52 mcg doses 52 HBeAg + 52 remission CR 52 μg d 52 #μg [002] 52 beclomethasone dipropionate 52 placebo PBO 52 lactate dehydrogenase 52 Free Survival PFS 52 mutated K ras 52 CIMZIA TM certolizumab pegol 52 BARACLUDE ® 52 elevated ALT 52 â ‰ ¥ 52 nadroparin 52 sustained virologic response 52 serum urate 52 urine albumin 52 treatment naive genotype 52 timepoint 52 leukocyte count 52 tumors GIST 52 peginterferon alfa 2a #KD 52 receiving INTRON 52 PSADT 52 IELT 52 sUA 52 iPTH 52 detemir 52 biochemical recurrence 52 budesonide pMDI 52 #mg BID [001] 52 chlorambucil 52 dexamethasone Decadron 52 mm3 52 octreotide LAR 52 hyperphenylalaninemia HPA due 52 neutrophil count 52 virologic response 52 tolterodine ER 52 aPTT 52 mCRPC 52 neutropenia dehydration dyspnea 52 CD3 + 52 humanized interleukin 6 52 CD4 lymphocyte count 52 PEGylated anti 52 adjunctive placebo 52 complete cytogenetic 51 P = .# 51 μg liter 51 Stage IIB 51 comparator arm 51 Bezielle 51 #mg dose [002] 51 R abatacept 51 antiretroviral naive 51 HBeAg positive 51 FUSILEV enhances 51 paraprotein 51 erythrocyte sedimentation rate 51 mg subcutaneous 51 FIRMAGON 51 Pegylated Interferon 51 hemoglobin A1c HbA1c 51 cytogenetic responses 51 LEXIVA r 51 microg 51 lowest tertile 51 EGFR TKI 51 titers 51 mg/m2 51 plasma glucose 51 histologically confirmed 51 colorectal carcinoma 51 baseline Hb 51 alfa 2a 51 ribavirin therapy 51 dasatinib Sprycel ® 51 CrCl 51 castrate resistant 51 Index CDAI score 51 sUA levels 51 mg dosed twice 51 Natalizumab 51 concentration Cmax 51 PASI scores 51 cells uL 51 cells mcL 51 GHz RF transceiver 51 prior chemotherapy regimens 51 #ng/ml 51 emtricitabine tenofovir 51 KRAS mutations occur 51 hematologic toxicity 51 nucleoside analog 51 Forodesine HCl 51 TDF FTC 51 HGPIN 51 golimumab CNTO 51 x ULN 51 Folfox 51 leukemia AML 51 sustained virological response 51 adriamycin 51 operable breast cancer 51 transaminases 51 seropositive 51 naïve HCV 51 ABC/3TC 51 doxorubicin cyclophosphamide 51 serum concentrations 51 patients coinfected 51 reduce serum phosphate 50 plus OBT 50 Thal Dex 50 PREZISTA ritonavir 50 #.#ng/ml 50 highly emetogenic 50 nanomolar 50 hemoglobin Hb 50 NovoLog ® Mix 50 seroprotective 50 Lenalidomide 50 infliximab monotherapy 50 amprenavir 50 mm ³ 50 mcL 50 evaluable 50 morphometric vertebral fractures 50 highest tertile 50 TAXOTERE R 50 dehydroepiandrosterone sulfate 50 telaprevir dosed 50 % CI #.#-#.# [007] 50 achieve sustained virological 50 μg doses 50 LHRH agonists 50 mEq L 50 mcg Albuferon 50 Crohn Disease Activity 50 insulin detemir 50 plasma leptin 50 peginterferon alpha 2a 50 glulisine 50 bioavailable testosterone 50 normal ULN 50 low dose cytarabine 50 GnRH agonist 50 #mg #mg #mg [003] 50 T2DM 50 Relapsed Refractory 50 receiving ISENTRESS 50 baseline LDH 50 mg BID 50 serum potassium 50 neutrophil counts 50 LVTTL 50 median CD4 50 plus medroxyprogesterone acetate 50 evaluable subjects 50 copies ml 50 #.# MHz [002] 50 mitoxantrone 50 fluticasone propionate FP 50 q8h 50 gemcitabine cisplatin 50 mIU mL 50 intramuscularly 50 triglyceride concentrations 50 irbesartan 50 interquartile range 50 mg d 50 XL# administered orally 50 mesalamine granules 50 LX#T 50 Amgen Neulasta ® 50 bortezomib refractory 50 ALT elevations 50 CDAI score 50 haematological toxicity 50 imatinib therapy 50 oxycodone CR 50 CsA 50 DAS# remission 50 pegylated interferon alfa 2a 50 p = #.# [003] 50 #.#g/day 50 nevirapine NVP 50 methylmalonic acid 49 weekly subcutaneous injections 49 tenofovir emtricitabine 49 serum urate levels 49 anthracycline taxane 49 cART 49 hepatorenal syndrome 49 CDAI 49 K ras mutations 49 autoantibody levels 49 HER2 expression 49 annualized relapse 49 CK MB 49 serum testosterone 49 Hazard Ratio 49 mg eq 49 IXEMPRA 49 biologic DMARD 49 REYATAZ r 49 TRAIL induced apoptosis 49 rizatriptan 49 ULN 49 refractory NSCLC 49 5-FU/LV 49 nonmetastatic 49 aminotransferase levels 49 #Gy 49 Mg Uk 49 combination antiretroviral therapy 49 oral prednisone 49 lipid elevations 49 acute GvHD 49 anti HBs 49 FOLFIRI 49 ORENCIA ® 49 cells/mm3 49 doxorubicin docetaxel 49 mcg linaclotide 49 experienced virologic failure 49 forodesine 49 indinavir 49 pegIFN 49 mg q#h 49 mucosal healing 49 HIV uninfected 49 plus ribavirin 49 evaluating tivozanib 49 coinfected 49 FOLFOX4 alone 49 R entecavir 49 HbA 1c levels 49 recurrent glioblastoma multiforme 49 Hb A1C 49 BENICAR HCT 49 low dose Iluvien 49 p = .# [002] 49 mmol L 49 nonnucleoside reverse transcriptase inhibitors 49 HIV coinfected 49 APTIVUS r 49 ipsilateral stroke 49 Kaplan Meier analysis 49 mU L 49 Zidovudine Tablets 49 binary restenosis 49 virologic suppression 49 deep venous thromboses 49 ml kg 49 ALT flares 49 HBeAg negative 49 myelodysplastic myeloproliferative diseases 49 microliter 49 viral titers 49 FTC TDF 49 milliliters mL 49 unresectable tumors 49 Laquinimod 49 CW# [001] 49 FOLFOX4 49 recurrent genital herpes 49 e antigen HBeAg 49 CD4 + cells 49 underwent resection 49 anthracycline containing 49 distant metastasis 49 Median survival 49 leucopenia 49 adenoma recurrence 49 Capecitabine 48 pCR 48 GnRH antagonist 48 mIU L 48 achieved sustained virologic 48 Kaplan Meier estimates 48 glycated hemoglobin levels 48 plasma concentrations 48 IgM 48 oral FTY# 48 #mg/dl 48 liver enzymes ALT 48 splenectomized patients 48 ACR# response 48 treatment naïve genotype 48 placebo p 48 #mg/day [001] 48 antibody titers 48 adjunctive ABILIFY 48 absolute neutrophil count 48 blood phenylalanine Phe 48 micrograms mL 48 serum albumin 48 ertapenem 48 lamivudine refractory patients 48 AZT 3TC 48 NNRTI resistance 48 tirofiban 48 GMII 48 umol L 48 advanced adenoma 48 aminotransferases 48 mcg dose 48 daunorubicin 48 adefovir 48 generalized edema 48 baseline A1C 48 Evaluation Module 48 NASDAQ DSPG 48 serum phosphate levels 48 Myelosuppression 48 HES CEL 48 plus dexamethasone 48 Platinol ® cisplatin 48 placebo dexamethasone 48 platelet reactivity 48 #.#um CMOS 48 ovarian carcinoma 48 creatinine clearance 48 ACLR 48 JEDEC specification 48 metastatic renal cell 48 plus COPEGUS 48 EGFR mutation positive 48 autoantibody positive 48 Index CDAI 48 genotype 1b 48 g dl 48 posaconazole 48 peg interferon 48 Epoetin Alfa 48 REYATAZ ® 48 endometrial thickness 48 COPEGUS 48 advanced hepatocellular carcinoma 48 mcg kg REBETOL 48 bone marrow reticulin deposition 48 mcg albinterferon alfa 2b 48 hip BMD 48 #.#dBm 48 plasma folate 48 Zometa hazard 48 CD4 + cell 48 serum phosphorus levels 48 G.# compliant 48 Kivexa 48 Peginterferon Alfa 2a 48 IFN alfa 48 mg m 48 seroprotection 48 COMBIVIR 48 peg IFN 48 Cutaneous T 48 albumin excretion rate 48 gout flares 48 ACR# responses 48 stage IIIB 48 Peginterferon alfa 2b 48 peginterferon alfa 2b 48 debulking surgery 48 lopinavir 47 cytidine nucleoside analog 47 definite stent thrombosis 47 X ULN 47 Telintra 47 Zoledronic acid 47 T2 lesion volume 47 kBq kg 47 nevirapine Viramune 47 histologic subtype 47 HBeAg negative patients 47 β blocker 47 MAGE A3 ASCI 47 mOhm 47 HD SDI SDI 47 sigma delta 47 achieved PASI 47 LPV r 47 virologically 47 peginterferon 47 telaprevir pegylated interferon 47 EBRT 47 resistant hormone refractory 47 NNRTIs 47 rilpivirine 47 underwent liver transplantation 47 dBFS 47 mg tid 47 mmol liter 47 recurrent NSCLC 47 poor metabolizers 47 adefovir treated 47 recurrent metastatic 47 dB SNR 47 interferon alfa 2b 47 bone metastasis 47 HCV genotype 47 Quadrature Phase Shift Keying 47 ceftriaxone 47 peginterferon alfa 2a 47 urinary albumin excretion 47 Noise Ratio 47 DOXIL ® 47 pulmonary exacerbation 47 RF Tuner 47 mRCC 47 Digital Converter ADC 47 paclitaxel carboplatin 47 postmenopausal osteoporotic women 47 mmHg diastolic 47 gastric pH 47 interferon alfa 2a 47 Frequency Synthesizer 47 FOLPI 47 moderate renal impairment 47 reactogenicity 47 androgen independent 47 neuropathy sensory 47 HCV infected 47 cisplatin chemotherapy 47 baseline CD4 47 ng dl 47 endometrial ovarian 47 Peginterferon 46 chronic HCV genotype 46 lopinavir ritonavir plus 46 RFX# 46 Gbps SDI 46 gastrointestinal stromal tumors 46 Vitesse FlexEQ 46 castrate resistant prostate cancer 46 prior nephrectomy 46 leukopenia 46 EDSS score 46 HbA1C 46 mCi m 2 46 oral clodronate 46 Switch Module 46 protein excretion 46 seropositive patients 46 argatroban 46 pegfilgrastim 46 OADs 46 mm Hg systolic 46 concomitant antibiotics 46 virus HBV 46 undetectable viral load 46 treatment naļve 46 CDI recurrence 46 cervical intraepithelial neoplasia 46 NMIBC 46 + PH# 46 RLAI 46 #Ω [002] 46 febrile neutropenia 46 Viread Emtriva 46 baseline HbA1c 46 PEG Interferon alfa 46 ng mL 46 hemoglobin concentrations 46 Phase Locked Loops 46 hypomagnesemia 46 sampling oscilloscope 46 recurrent VTE 46 virologically suppressed 46 seroconversion 46 micromoles 46 ME#L 46 abnormal cytology 46 SAR ADC 46 transaminase levels 46 ARCOXIA 46 tipranavir ritonavir 46 investigational oral inhibitor 46 MMSE 46 Psoriasis Area 46 mg calcium 46 nadir CD4 cell 46 #mmHg [001] 46 virologic responses 46 fallopian tube carcinoma 46 nmol l 46 amoxicillin clavulanate 46 trabedersen 46 tipranavir 46 CIN3 46 dacarbazine 46 DMOS 46 CLINICAL STUDIES 46 NRTI backbone 46 serum uric acid 46 nmol L 46 progesterone receptor negative 46 Treatment Naive Patients 46 prednisone prednisolone 46 DRX #D 46 deserializer 46 receiving immunosuppressive therapy 46 MULTAQ 45 minimally symptomatic metastatic castrate 45 oral vancomycin 45 VIRAMUNE XR 45 TC HDL 45 nucleoside naive 45 chronic HCV infection 45 3TC lamivudine Epivir 45 alemtuzumab treated 45 antidiabetic drug 45 Pressure Transducer 45 CI #.#-#.# [001] 45 NPH insulin 45 baseband MAC 45 HER2 negative 45 #.#Gbit s [001] 45 receiving APTIVUS r 45 HBV infections 45 decompensated liver disease 45 delta sigma 45 leukocytosis 45 extracapsular extension 45 antiandrogens 45 ZOLINZA 45 fosamprenavir 45 hormone receptor negative 45 2kHz 45 iniparib BSI 45 CMV seropositive 45 virological failure 45 LEXIVA 45 Acute myeloid leukemia 45 megabit Mb 45 serializer deserializer 45 SHPT 45 A1c levels 45 thyrotropin levels 45 Guides FY# Quick Facts 45 voiceband 45 Fractional N 45 anemia hemoglobin 45 DAPT 45 Neutrophil 45 Hb levels 45 microlitre 45 serum folate 45 J Am Coll 45 PTI COR 45 serum creatinine levels 45 viremia 45 HBsAg positive 45 Hgb 45 Contrave# 45 protease inhibitor PI 45 diplexer 45 Agilent #A [001] 45 #Ω [001] 45 Protocol Stack 45 % CI #.#-#.# [006] 45 neoadjuvant 45 advanced adenomas 45 mmHg systolic 45 Downlink 45 varactors 45 glomerular filtration rate 45 docetaxel Injection Concentrate 45 tamoxifen Nolvadex ® 45 #.#μm CMOS 45 STA# [001] 45 DAS# [002] 45 KRAS mutations 45 kbit 45 Arria GX FPGAs 45 -#.# dBm 45 Doxil ® 45 IEEE#v# 44 Vdd 44 prevalent vertebral fracture 44 Scale EDSS score 44 DOXIL 44 JESD# [002] 44 Paraplatin ® 44 HCV genotype 1 44 intravesical chemotherapy 44 TMS#F# 44 T Increment 44 TroVax ® 44 MBd 44 Crosspoint Switch 44 aromatase inhibitor therapy 44 ALND 44 MIPS# #K 44 Pemetrexed 44 peginterferon alfa 44 ng ml 44 Durezol 44 SPI I2C 44 Declares Dividend Quick Facts 44 administering XIFAXAN 44 noise ratio SNR 44 Wideband Networking Waveform 44 Pred Forte 44 HDMI Transmitter 44 epithelial ovarian 44 KRAS mutant tumors 44 HbA1C levels 44 viral load 44 g dL 44 heavily pretreated 44 NSTE ACS 44 virological suppression 44 Metal Oxide Semiconductor 44 TNF antagonist 44 UNI XC 44 G.# G.# 44 palifermin 44 plasma viremia 44 pulmonary exacerbations 44 AMR NB 44 undergone splenectomy 44 #.#mohm 44 Q TOF LC 44 homocysteine concentrations 44 deterministic jitter 44 del 5q MDS 44 mg dL 44 androgen deprivation 44 Signal Generator 44 BCIRG 44 FluCAM 44 vitamin D2 44 TGA# SM 44 AWG# 44 ADSP BF# 44 CD4 + 44 sigma delta ADC 44 BCG vaccinated 44 Inhibin B 44 imipenem 44 downconverter 44 hepatitis C genotype 43 8PSK 43 absolute lymphocyte 43 DQPSK 43 incidence ≥ 43 Fmax 43 Pearson correlation coefficient 43 CD4 T 43 NATRECOR R 43 ASCUS 43 mg Lucentis 43 ADMP# 43 viral loads 43 STLC# 43 oxycodone IR 43 thyroid stimulating hormone 43 zidovudine lamivudine 43 epithelial ovarian cancer 43 preoperative chemotherapy 43 doublet chemotherapy 43 dizziness nausea diarrhea 43 p#HER# positive 43 #mg dose [003] 43 lamivudine 43 Mixed Signal IC 43 ParBERT 43 Agilent MXG 43 Bipolar CMOS DMOS 43 LDO voltage regulator 43 8kHz 43 AES EBU audio 43 adult chronic ITP 43 Input Voltage 43 systemic embolism 43 baseline CD4 + 43 metastatic GIST 43 Arbitrary Waveform Generator 43 alteplase 43 I2C serial 43 decitabine 43 RBC transfusion 43 Programmable Logic Devices 43 #OHD levels 43 TRF# [001] 43 LVDS output 43 basal cell carcinoma BCC 43 LVPECL 43 SPI interfaces 43 Kidney Int 43 hypogonadal 43 PREZISTA r 43 ADC DAC 43 Lithium Niobate 43 #.#mmHg 43 #.#V #.#V [001] 43 mcg 43 Phase Locked Loop 43 #dB attenuation 43 VIRAMUNE 43 Agilent MXA 43 severe renal impairment 43 relapsed ovarian cancer 43 chronic HBV 43 MRCY 43 #MHz bandwidth 43 SYMM 43 Stratix III 43 serum PSA 43 ZMD# 43 CMV disease 43 ABRAXANE therapy 43 lamivudine monotherapy 43 SDIO interface 43 viral suppression 43 Bi Directional 43 BRCA2 mutation carriers 43 GSa s 43 synchronous buck converter 43 monolithic microwave integrated 43 Fast Fourier Transform FFT 43 frequency synthesizer 42 Bidirectional 42 PECL 42 Infiniium 42 kS s 42 CONVERTERS 42 MODULE 42 CD4 + T 42 jitter measurement 42 #u [001] 42 benazepril 42 TLV#AIC# 42 osteopenic 42 SiW# 42 PASI score 42 CMX# [002] 42 HIV HCV coinfected 42 Guides FY# Update 42 AAC LC 42 G CSF 42 MT#C 42 Arch Intern Med 42 E pHEMT 42 onset idiopathic hypogonadism 42 gastrointestinal stromal tumors GIST 42 MPEG4 AAC 42 noncarriers 42 initiating HAART 42 Optical Module 42 servo controller 42 serum testosterone levels 42 Agilent L#A 42 prostate cancer mCRPC